Photo: Kennet Ruona/Malin Parmar
My group works with translational stem cell biology. The focus of my research is to understand cell fate specification in the developing brain and in human neural progenitor cells using cell-based models of neuronal differentiation. Our current focus is to learn how to direct and efficiently drive controlled differentiation of human stem cells into subtype-specific neurons. We also develop technologies for direct conversion of human fibroblasts into functional and subtype-specific neurons in vitro, and the conversion of endogenous glia into neurons in vivo.
The ultimate aim is to develop these cells and technologies for use in brain repair, with focus on Parkinson’s disease.
2017-12-15. Our warmest congratulations to Dr. Maria Pereira who defended her PhD thesis Cell reprogramming as a way to produce new functional neurons today. We wish you all the best for your future, Maria!
2017-11-30. We are very happy and proud to announce that Malin Parmar has been awarded the very distinguished and competitive ERC Consolidator Grant from the European Research Council! Malin is one of the 329 top researchers across Europe who received the grant. Her project is entitled “Patient specific treatment for Parkinson’s disease using reprogrammed skin cells” and will run between 2018-2022. Congratulations Malin!
2017-11-30. Our research group has recently visited and participated in the exhibition “The invisible bodies” taking place at the Sven-Harrys Art Museum in Stockholm. We contributed with three high resolution images to this fantastic art project aiming at increasing the public's understanding of science. The exhibition runs until January 7th, 2018 and it shows pictures used in research, tells stories on what researchers do, how they do it, and how fascinating it is!
2017-11-30. Congratulations to Daniella Ottosson on being awarded a prestigious project grant of 6 million SEK from the Swedish Research Council! Daniella’s project will focus on creating new interneurons in the brain which might prove to be the future of the cell therapy for brain diseases.